









Markets
/
Stocks
/
nasdaq-sbc
/

SBC Medical Group Holdings Inc

SBC

3.150USD

+0.070+2.27%

Close 11/07, 16:00（ET）Quotes delayed by 15 min

324.76MMarket Cap

9.74P/E TTM



SBC Medical Group Holdings Inc

3.150

+0.070+2.27%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of SBC Medical Group Holdings Inc

Currency: USD Updated: 2025-11-07

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered undervalued,and institutional recognition is high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a very weak stock market performance, the company shows strong fundamentals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

SBC Medical Group Holdings Inc's Score

Industry at a Glance

Industry Ranking

102 / 160

Overall Ranking

293 / 4614

Industry

Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 1 analysts

Buy

Current Rating

7.750

Target Price

+151.62%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

SBC Medical Group Holdings Inc Highlights

StrengthsRisks

SBC Medical Group Holdings Incorporated is a global owner, operator and provider of management services and products to cosmetic treatment centers. The Company, through its subsidiaries, provides services to support the operation of clinics that deliver highly specialized medical services in the areas of cosmetic medicine, esthetic dentistry, and Androgenetic Alopecia (AGA), primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. It provides management services to a total of 164 franchisee treatment centers located in Japan. The Company also owns and operates one treatment center in Vietnam and provides management services to one treatment center in State of California in the United States. It is focused on providing comprehensive management services to franchisee clinics, including advertising and marketing needs across various platforms, staff management, booking reservations for franchisee clinic customers, construction and design of franchisee clinics, and others.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.95% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 205.42M.

Undervalued

The company’s latest PE is 7.99, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 641.32K shares, decreasing 71.91% quarter-over-quarter.

Held by Murray Stahl

Star Investor Murray Stahl holds 1.38K shares of this stock.

Financial Health

Currency: USD Updated: 2025-11-07

The company's current financial score is 7.05, which is lower than the Professional & Commercial Services industry's average of 7.31. Its financial status is robust, and its operating efficiency is low. Its latest quarterly revenue reached 43.36M, representing a year-over-year decrease of 18.35%, while its net profit experienced a year-over-year decrease of 86.70%.

Score

Industry at a Glance

Previous score

7.05

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

2.96

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

5.79

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.11

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.40

Key Metrics

Free cash flow

No Data

SBC Medical Group Holdings Inc's Company Valuation

Currency: USD Updated: 2025-11-07

The company’s current valuation score is 8.39, which is higher than the Professional & Commercial Services industry's average of 7.13. Its current P/E ratio is 7.99, which is 410.14% below the recent high of 40.74 and 100.00% above the recent low of 0.00.

Score

Industry at a Glance

Previous score

8.39

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 102/160

No Data

Earnings Forecast

Currency: USD Updated: 2025-11-07

The company’s current earnings forecast score is 8.00, which is higher than the Professional & Commercial Services industry's average of 7.66. The average price target for SBC Medical Group Holdings Inc is 7.75, with a high of 9.00 and a low of 6.50.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

No Data

Analyst Rating

Based on 1 analysts

Buy

Current Rating

7.750

Target Price

+151.62%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

SBC Medical Group Holdings Inc

SBC

PayPal Holdings Inc

PYPL

Block Inc

XYZ

Visa Inc

Fiserv Inc

Global Payments Inc

GPN

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-11-07

The company’s current price momentum score is 3.41, which is lower than the Professional & Commercial Services industry's average of 7.01. Sideways: Currently, the stock price is trading between the resistance level at 3.94 and the support level at 2.72, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

3.37

Change

0.04

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(1)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.101

Sell

RSI(14)

26.096

Sell

STOCH(KDJ)(9,3,3)

6.839

Oversold

ATR(14)

0.194

Low Volatility

CCI(14)

-88.824

Neutral

Williams %R

93.458

Oversold

TRIX(12,20)

-1.095

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

3.188

Sell

MA10

3.334

Sell

MA20

3.682

Sell

MA50

4.072

Sell

MA100

4.316

Sell

MA200

4.200

Sell

Institutional Confidence

Currency: USD Updated: 2025-11-07

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Aikawa (Yoshiyuki)

92.69M

-0.29%

BlackRock Institutional Trust Company, N.A.

252.13K

Geode Capital Management, L.L.C.

98.08K

+1771.79%

The Vanguard Group, Inc.

Star Investors

35.08K

SBI Securities Co., Ltd.

54.18K

+227.27%

Citadel Advisors LLC

29.37K

Northern Trust Investments, Inc.

27.68K

State Street Investment Management (US)

20.20K

New York State Common Retirement Fund

22.40K

BlackRock Investment Management, LLC

16.69K

Risk Assessment

Currency: USD Updated: 2025-11-07

The company’s current risk assessment score is 2.85, which is lower than the Professional & Commercial Services industry's average of 5.57. The company's beta value is 0.00. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.